Lenire Tinnitus Treatment Device Available in Canada
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
New research published in JASA suggests that in noisy settings, visual engagement improves auditory sensitivity.
These evidence-based clinical recommendations emphasizing holistic care provide actionable ways for hearing care professionals to address the complex relationship between hearing and cognition in their practices.
The campaign uses international ambassadors to promote hearing health awareness in major public venues in the US, Belgium, and Japan.
The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.
The partnership makes the bimodal neuromodulation device for tinnitus available through clinics in Philadelphia and Charlotte.
The campaign includes free hearing tests, educational events, and a multi-country social media push to promote hearing health awareness.
A 14-year-old girl’s vestibular evaluation reveals overlapping signs of vestibular migraine and postural orthostatic tachycardia syndrome (POTS), complicating the diagnosis.
New research shows while overall traffic to low-credibility health sites is low, it is highly concentrated among seniors, particularly those who lean right politically.